Goodwin Procter LLP advised Allogene Therapeutics, Inc. on the deal. Allogene Therapeutics, Inc. (Nasdaq: ALLO) announced its formation of Allogene Overland Biopharm, a joint venture with…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
